Abbott Laboratories Stock price

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-02-09 pm EST 5-day change 1st Jan Change
111.8 USD -0.55% Intraday chart for Abbott Laboratories -0.27% +1.58%
Sales 2023 40.11B Sales 2024 * 41.98B Capitalization 194B
Net income 2023 5.72B Net income 2024 * 6.04B EV / Sales 2023 4.76 x
Net Debt 2023 * 6.36B Net Debt 2024 * 2.86B EV / Sales 2024 * 4.69 x
P/E ratio 2023
33.8 x
P/E ratio 2024 *
32.3 x
Employees 115,000
Yield 2023 *
1.84%
Yield 2024 *
1.96%
Free-Float 86.87%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.55%
1 week-0.27%
Current month-1.18%
1 month-0.82%
3 months+19.52%
6 months+6.18%
Current year+1.58%
More quotes
1 week
111.15
Extreme 111.15
114.60
1 month
109.74
Extreme 109.74
115.64
Current year
109.29
Extreme 109.29
115.64
1 year
89.67
Extreme 89.674
115.83
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 -
Director of Finance/CFO 51 96-12-31
Chief Tech/Sci/R&D Officer - 20-02-29
Members of the board TitleAgeSince
Director/Board Member 69 17-02-15
Director/Board Member 63 17-06-28
Director/Board Member 65 11-12-08
More insiders
Date Price Change Volume
24-02-09 111.8 -0.55% 5,947,680
24-02-08 112.4 -0.78% 6,980,455
24-02-07 113.3 -0.61% 4,757,532
24-02-06 114 +2.10% 4,734,844
24-02-05 111.6 -0.41% 5,670,059

Delayed Quote Nyse, February 09, 2024 at 04:00 pm EST

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (38%); - vascular devices (21%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (17.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (11.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (12.7%). Net sales are distributed geographically as follows: the United States (41.5%), Germany (5.4%), China (4.9%), Japan (4.4%), India (3.8%), Switzerland (3.1%), Canada (2.9%) and other (34%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
111.8 USD
Average target price
124.5 USD
Spread / Average Target
+11.38%
Consensus
  1. Stock
  2. Equities
  3. Stock Abbott Laboratories - Nyse
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer